A prospective study to determine the predictive ability of hypertensive disorders during pregnancy-gestosis score for the development of pre-eclampsia

Pavithra Reddy; Chaitanya Indrani; Vandana Vydyanath

doi:10.18203/2320-1770.ijrcog20242989

Authors

Pavithra Reddy Department of Obstetrics and Gynecology, MVJ MC and RH, Bangalore, Karnataka, India
Chaitanya Indrani Department of Obstetrics and Gynecology, MVJ MC and RH, Bangalore, Karnataka, India
Vandana Vydyanath Department of Obstetrics and Gynecology, MVJ MC and RH, Bangalore, Karnataka, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20242989

Keywords:

HDP score, Gestosis, Preeclampsia, Prediction

Abstract

Background: Hypertensive disorders during pregnancy (HDP)-gestosis score is a risk scoring system (score 1-3) for the development of pre-eclampsia. When a pregnant woman’s total score is equal to or greater than 3, she is labelled as “at risk for pre-eclampsia” and is managed accordingly. Objectives were to determine the sensitivity, specificity, and diagnostic accuracy of HDP-gestosis score for predicting pre-eclampsia (PE).

Methods: This prospective study included 100 pregnant women who presented at the department of obstetrics and gynaecology. After 20 weeks of pregnancy, the patients were assessed for the development of pre-eclampsia. Details of age, gravida, obstetric history, menstrual cycle regularity, polycystic ovarian disease history, duration of marriage, parity, past medical and surgical intervention, previous/present medication, and family history were taken. Gestosis score was calculated and classified into mild (score of 1), moderate (score of 2) and high risk (score of ≥ 3) for the development of PE. Sensitivity, specificity, and diagnostic accuracy of HDP-gestosis score for predicting the development of PE were determined.

Results: The mean age, gestational age, and body mass index (BMI) of the women were 28.4±6.8 years, 11.5±2.04 weeks, and 24.5±3.7 kg/m², respectively. The gestosis score was 2 in 43.13% of the participants, 1 in 42.28%, and ≥3 in 14.59% of the women. PE developed in 15.01% (n=71) participants. The sensitivity, specificity, PPV, NPV, and diagnostic accuracy of HDP-gestosis score for predicting PE were 83.1%, 97.51%, 85.51%, 97.03% and 95.35%, respectively.

Conclusions: Gestosis score is a novel early marker for prediction of the development of PE allowing for a prompt management for the patients, thereby curbing the adverse consequences.

Metrics

Metrics Loading ...

References

Yang Y, Le Ray I, Zhu J, Zhang J, Hua J, Reilly M. Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China. JAMA Netw Open. 2021;4(5):e218401.

Mou AD, Barman Z, Hasan M, Miah R, Hafsa JM, Das Trisha A, Ali N. Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh. Sci Rep. 2021;11(1):21339.

Dhinwa M, Gawande K, Jha N, Anjali M, Bhadoria AS, Sinha S. Prevalence of hypertensive disorders of pregnancy in India: a systematic review and meta-analysis. J Med Evid. 2021;2:105-12.

FOGSI-gestosis-ICOG. Hypertensive Disorders in Pregnancy (HDP). Good Clinical Practice Recommendations 2019.

Imam ST. Improvement in the cases of hypertensive disorder of pregnancy with help of HDP-gestosis score. Int J Reprod Contracept Obstet Gynecol. 2023;12:671-4.

Gupta M, Yadav P, Yaqoob F. A Prospective Study to Determine the Predictive Ability of HDP-Gestosis Score for the Development of Pre-eclampsia. J Obstet Gynaecol India. 2022;72(6):485-91.

Mishra SS, Mohanty S, Ghadei R, Pradhan S, Majhi PP. HDP-gestosis score as a predictor of Pre-eclampsia. IJSR. 2020;9(8):25-8.

Ruman U, Naz M, Rhaman MM, Rhaman MM. Hypertensive Disorders in Pregnancy-Gestosis Scoring can Predict the Launching of a Deadly Missile-Preeclampsia. J Obstet Gynaecol Pract POGS. 2023;1(2):54-7.

Manhar R, Ghanghoriya V, Khan A, Mandloi K. A study of gestosis score for HDP at 12- 20 weeks and it's evaluation for prediction of pre-eclampsia. Int J Acad Med Pharm. 2023;5(5):335-40.

Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The international federation of gynecology and obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145(1):1-33.

Sravani R, Reddy GP. HDP gestosis score as a predictor of PIH. Int J Clin Obstetr Gynaecol. 2022;(6):5.

Sovio U, Smith GC. Evaluation of a simple risk score to predict preterm pre‐eclampsia using maternal characteristics: a prospective cohort study. BJOG: Int J Obstetr Gynaecol. 2019;126(8):963-70.

Parthasarathy AKKA, Madhumitha J, Manohar S. An observational study of evaluation of extended first trimester screening test to predict early preterm pre eclampsia in pregnant women. Int J Reprod Contracept Obstet Gynecol. 2022;11(7):1988-93.

Goetzinger KR, Tuuli MG, Cahill AG, Macones GA, Odibo AO. Development and validation of a risk factor scoring system for first-trimester prediction of preeclampsia. Am J Perinatol. 2010;31(12):1049-56.

Lewandowska M. The association of familial hypertension and risk of gestational hypertension and preeclampsia. Int J Environ Res Public Health. 2021;18(13):7045.

Ehrenthal DB, Jurkovitz C, Hofman M, Jiang X, Weintraub WS. Pre-pregnancy body mass index as an independent risk factor for pregnancy-induced hypertension. J Women’s Health. 2011;20(1):67-72.

Lewandowska M, Więckowska B, Sajdak S. Pre-pregnancy obesity, excessive gestational weight gain, and the risk of pregnancyinduced hypertension and gestational diabetes mellitus. J Clin Med. 2020;9(6):1980.

Einarsson JI, Sangi-Haghpeykar H, Gardner MO. Sperm exposure and development of preeclampsia. Am J Obstet Gynecol. 2003;188(5):1241-3.